June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Identifying Invasion-Promoting Molecular Pathways In Retinoblastoma
Author Affiliations & Notes
  • Laura Asnaghi
    Dept of Pathology, Sch of Med, Johns Hopkins University, Baltimore, Maryland, United States
  • Alka Mahale
    King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  • Hind Alkatan
    Department of Ophthalmology, King Saud University, Riyadh, Saudi Arabia
  • Deepak P Edward
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States
    King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  • Wayne Yu
    Microarray Core Facility, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland, United States
  • Saleh Al Mesfer
    King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  • Azza Maktabi
    King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  • Leen Abu Safieh
    King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
  • Charles Eberhart
    Dept of Pathology, Sch of Med, Johns Hopkins University, Baltimore, Maryland, United States
    Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Laura Asnaghi, None; Alka Mahale, None; Hind Alkatan, None; Deepak Edward, None; Wayne Yu, None; Saleh Al Mesfer, None; Azza Maktabi, None; Leen Abu Safieh, None; Charles Eberhart, None
  • Footnotes
    Support  Financial support: King Khaled Eye Specialist Hospital (KKESH) – Wilmer Eye Institute (WEI) Collaborative Research Grant
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 857. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Laura Asnaghi, Alka Mahale, Hind Alkatan, Deepak P Edward, Wayne Yu, Saleh Al Mesfer, Azza Maktabi, Leen Abu Safieh, Charles Eberhart; Identifying Invasion-Promoting Molecular Pathways In Retinoblastoma. Invest. Ophthalmol. Vis. Sci. 2017;58(8):857.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinoblastoma is the most frequent malignant intraocular cancer in children. In advanced cases, dissemination in the CNS or metastasis to distant organs can lead to death. Our goal was to identify the molecular drivers and signaling pathways associated with tumor invasion and metastatic spread into the optic nerve and choroid in order to develop new prognostic markers and therapeutic targets.

Methods : RNA extracted from eleven snap frozen retinoblastoma specimens was analyzed by RNA-seq (low input, non-strand specific). Samples were divided between invasive (retrolaminar, n=4; intralaminar, n=1) and non-invasive (prelaminar, n=4, no optic nerve invasion, n=2). Four cases with optic nerve invasion and two without also showed focal (<3mm) choroidal invasion, but none had massive choroidal invasion.

Results : We found 267 genes whose expression was modified more than two-fold in invasive versus non-invasive retinoblastomas: 27 upregulated and 240 downregulated. In the invasive cohort, we observed about 28-fold induction of DLX6, a transcription factor known to enhance migration and invasion by upregulating Twist1, and 11-fold induction of the matrix metallo-proteinase MMP12, which promotes invasion by degrading the extracellular matrix. We also found 24-fold reduction in WIF1 (WNT Inhibitory Factor 1), a tumor suppressor epigenetically silenced in various cancers, 16-fold reduction in CLUSTERIN, associated with apoptosis, and 11-fold decrease in GLI3, an inhibitor of Sonic hedgehog signaling.

Conclusions : Our gene expression profile analysis showed that several genes and pathways were differentially expressed in invasive versus non-invasive retinoblastomas. In particular WNT, Sonic hedgehog, and MMP signaling might be responsible for driving CNS dissemination in retinoblastoma. Functional studies are in progress to confirm these data in retinoblastoma lines.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×